Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line
Clinical trial NCT01127841 · UNKNOWN
Trial details
- NCT number
- NCT01127841
- Sponsor
- Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.